UBS(Lux)E.F.-Biotech(USD)QL a.USD
WKN A2QBCD | ISIN LU2208649280 | Fonds
Fonds
| ISIN | Name | Performance | Volatilität | Sharpe Ratio | ||
|---|---|---|---|---|---|---|
| 1 | CH0113817123 | Bellevue Biotech DT CHF | +3,83 % | +18,19 % | 0,07 |
|
| 2 | LU1269736838 | Candriam Equities L Biotech.R EUR Acc | +1,74 % | +18,09 % | -0,04 |
|
| 3 | LU1120766032 | Candriam Equities L Biotech.I EUR Acc | +1,58 % | +17,84 % | -0,05 |
|
| 4 | LU2026682919 | Candriam Equities L Biotech.V2 USD Acc | +1,44 % | +17,71 % | -0,06 |
|
| 5 | LU0942225912 | Candriam Equities L Biotech.R USD Acc | +1,20 % | +17,70 % | -0,07 |
|
| 41 | LU2208649280 | UBS(Lux)E.F.-Biotech(USD)QL a.USD | -3,77 % | +19,15 % | -0,33 |
|
| 73 | LU0774687577 | Franklin Templeton Investment Funds Franklin Biotechnology Discovery Fund Klasse Z (acc) GBP | -9,67 % | +17,82 % | -0,68 |
|
| 74 | LU1803069274 | F.Biotechnology Dis.Fd.A-H1 EUR H | -10,93 % | +18,93 % | -0,71 |
|
| 75 | LU0959058974 | Franklin Templeton Investment Funds Franklin Biotechnology Discovery Fund Klasse A (acc) CHF-H1 | -13,17 % | +18,99 % | -0,83 |
|
| 76 | DE000A3DCA95 | BIT Biotech Opportunities S | -31,09 % | +29,66 % | -1,14 |
|
| 77 | DE000A3DCBA0 | BIT Biotech Opportunities I-II | -31,25 % | +29,65 % | -1,14 |
|